Literature DB >> 11738360

Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice.

Anne-Catherine Passaquin1, Mathilde Renard, Laurence Kay, Corinne Challet, Armand Mokhtarian, Theo Wallimann, Urs T Ruegg.   

Abstract

The mdx mouse serves as animal model for Duchenne muscular dystrophy. Energy status in muscles of mdx mice is impaired and we have demonstrated recently that the energy precursor creatine exerts beneficial effects on mdx skeletal muscle cells in culture. Here we show that feeding a creatine-enriched diet to new-born mdx mice strongly reduced the first wave of muscle necrosis four weeks after birth. Necrosis of the fast-twitch muscle extensor digitorum longus was inhibited by 63+/-14% (P<0.0001) while necrosis of the slow-twitch soleus muscle was not significantly decreased. In addition, using chemically skinned muscle fibres, we found that mitochondrial respiration capacity was decreased by about 25% in mdx-derived fibres and that long-term creatine-feeding restored respiration to wild-type levels. These results provide evidence that creatine supplementation in mdx mice improves muscle health and may provide a scientific basis for its use as adjuvant therapy in Duchenne muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11738360     DOI: 10.1016/s0960-8966(01)00273-5

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  35 in total

1.  Age-related T2 changes in hindlimb muscles of mdx mice.

Authors:  Ravneet S Vohra; Sunita Mathur; Nathan D Bryant; Sean C Forbes; Krista Vandenborne; Glenn A Walter
Journal:  Muscle Nerve       Date:  2015-07-14       Impact factor: 3.217

2.  Enhanced mitochondrial biogenesis is associated with the ameliorative action of creatine supplementation in rat soleus and cardiac muscles.

Authors:  Mennatallah A Gowayed; Shimaa A Mahmoud; Yousria El-Sayed; Nehal Abu-Samra; Maher A Kamel
Journal:  Exp Ther Med       Date:  2019-11-07       Impact factor: 2.447

3.  Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice.

Authors:  Sonia Messina; Domenica Altavilla; M'hammed Aguennouz; Paolo Seminara; Letteria Minutoli; Maria C Monici; Alessandra Bitto; Anna Mazzeo; Herbert Marini; Francesco Squadrito; Giuseppe Vita
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 4.  Creatine and the creatine transporter: a review.

Authors:  R J Snow; R M Murphy
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

Review 5.  Creatine for treating muscle disorders.

Authors:  Rudolf A Kley; Mark A Tarnopolsky; Matthias Vorgerd
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

6.  Beneficial effects of a Q-ter based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in rats.

Authors:  Jinze Xu; Arnold Y Seo; Darya A Vorobyeva; Christy S Carter; Stephen D Anton; Angela M S Lezza; Christiaan Leeuwenburgh
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

7.  Lack of functional benefit with glutamine versus placebo in Duchenne muscular dystrophy: a randomized crossover trial.

Authors:  Elise Mok; Guy Letellier; Jean-Marie Cuisset; André Denjean; Frédéric Gottrand; Corinne Alberti; Régis Hankard
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

8.  Phosphocreatine as an energy source for actin cytoskeletal rearrangements during myoblast fusion.

Authors:  Roddy S O'Connor; Craig M Steeds; Robert W Wiseman; Grace K Pavlath
Journal:  J Physiol       Date:  2008-04-17       Impact factor: 5.182

9.  Treatment options for Duchenne muscular dystrophy.

Authors:  Emma Ciafaloni; Richard T Moxley
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

Review 10.  Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Miranda D Grounds; Hannah G Radley; Gordon S Lynch; Kanneboyina Nagaraju; Annamaria De Luca
Journal:  Neurobiol Dis       Date:  2008-04-09       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.